M&A Deal Summary

Auxilium Pharmaceuticals Acquires Actient Pharmaceuticals

On April 29, 2013, Auxilium Pharmaceuticals acquired medical products company Actient Pharmaceuticals from GTCR and Fifth Street Capital for 585M USD

Acquisition Highlights
  • This is Auxilium Pharmaceuticals’ 1st transaction in the Medical Products sector.
  • This is Auxilium Pharmaceuticals’ largest (disclosed) transaction.
  • This is Auxilium Pharmaceuticals’ 1st transaction in the United States.
  • This is Auxilium Pharmaceuticals’ 1st transaction in Illinois.

M&A Deal Summary
Date 2013-04-29
Target Actient Pharmaceuticals
Sector Medical Products
Buyer(s) Auxilium Pharmaceuticals
Sellers(s) GTCR
Fifth Street Capital
Deal Type Add-on Acquisition
Deal Value 585M USD

Target

Actient Pharmaceuticals

Deerfield, Illinois, United States
Actient Pharmaceuticals, LLC (Actient) is a healthcare company focused on acquiring and operating specialty pharmaceutical companies and products. Actient targets opportunities that include products which are already approved or currently marketed, as well as late-stage development drugs.

Search 200,577 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Auxilium Pharmaceuticals

Malvern, Pennsylvania, United States
Category Company
Founded 1999
Sector Life Science
DESCRIPTION

Auxilium Pharmaceuticals (AUXL) develops and markets pharmaceutical products that focus on urology and sexual health. This includes commercialization of Testim Gel for male hypogonadism (low testosterone) and development of Xiaflex for connective tissue disorders such as Duputrens contracture and Peyronies disease.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Illinois) 1 of 1
Country (United States) 1 of 1
Year (2013) 1 of 1
Size (of disclosed) 1 of 1

Seller(S) 2

SELLER

GTCR

Chicago, Illinois, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1980
PE ASSETS 15.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

GTCR is a private equity firm that typically partners with management when pursuing acquisitions. The Firm looks to grow companies through build-on acquisitions, consolidations, and internal growth. GTCR will consider both equity and mezzanine capital commitments and concentrates its investment activity in consumer products & services, healthcare services, outsourced business services, technology, transaction processing, and pharma/medical products. GTCR was formed in 1980 and is based in Chicago, Illinois.

DEAL STATS #
Overall 40 of 84
Sector (Medical Products) 1 of 2
Type (Add-on Acquisition) 21 of 40
State (Illinois) 5 of 10
Country (United States) 40 of 81
Year (2013) 2 of 3
Size (of disclosed) 22 of 33
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-02-19 Wallace Theater

Portland, Oregon, United States

Wallace Theater is one of the nation’s largest motion picture exhibitors, with more than 500 screens located throughout twenty states and various international territories. Wallace is the leader in the theatrical exhibition industry, employing state-of-the-art theater design and offering movie patrons a cinematic viewing experience second to none. Stadium-seating, digital surround sound, widescreen presentations, and plush high-back theater seats combined with outstanding concessions and a greater choice of films make Wallace Theaters the preferred movie destination. Wallace continues to expand its footprint in the theater business with acquisitions and greenfield theater development.

Sell $191M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-08-02 Crealta Pharmaceuticals

Glendale, Wisconsin, United States

Crealta is a specialty pharmaceutical company focused on innovative therapeutics designed to improve patient outcomes. The company, which has two marketed medicines KRYSTEXXA and MIGERGOT, was formed to acquire, develop and market specialty medicines with a focus on select physician specialties.

Buy -
SELLER

Fifth Street Capital

Category Lender
Founded 1998
Size Mega
Type Sector Agnostic
DESCRIPTION

Fifth Street Capital is a public investment firm focused on providing mezzanine financing to support expansions, acquisitions, recapitalizations, and management buyouts of middle-market US based companies. Fifth Street looks to invest between $5 and $50 million per transaction. Sectors of interest include consumer products, healthcare services, manufacturing, medical device manufacturing, food services, business services, restaurants, speciality retail, logistics, and value added distribution. Fifth Street Capital is based in White Plains, New York.

DEAL STATS #
Overall 10 of 59
Sector (Medical Products) 3 of 5
Type (Add-on Acquisition) 5 of 27
State (Illinois) 1 of 3
Country (United States) 9 of 58
Year (2013) 5 of 9
Size (of disclosed) 5 of 10
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-04-08 CompuCom

Fort Mill, South Carolina, United States

CompuCom is a provider of end-to-end managed workplace services, infrastructure modernization, and digital consulting to enable the digital workplace for enterprise and mid-market organizations. CompuCom was founded in 1987 and is based in Fort Mill, South Carolina.

Sell $1.1B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-04-30 Pacific Press Technologies

Mount Carmel, Illinois, United States

Pacific Press Technologies is a manufacturer of highly engineered, specialized plastic and metal forming equipment, as well as complementary tooling, parts, refurbishment, and repair and maintenance services. Pacific Press Technologies was founded in 1945 and is based in Mount Carmel, Illinois.

Sell -
Mergr

Product

Company

Legal